Could a Pre-Transfer clot buster boost stroke recovery?

NCT ID NCT07253181

Recruiting now Disease control Sponsor: Xuanwu Hospital, Beijing Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether giving a clot-dissolving drug called Tenecteplase to stroke patients before they are moved to a hospital that can perform a clot-removal procedure improves their recovery. The trial involves 572 adults who had a stroke caused by a large blockage in the front part of the brain and who can be treated within 4.5 to 24 hours after symptoms began. The goal is to see if this early treatment leads to less disability compared to standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cerebral artery occlusion ischemic stroke large artery stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE ISCHEMIC STROKE LARGE VESSEL OCCLUSION TRANSPORTATION OF PATIENTS

Contacts and locations

Locations

Affiliated Hospital of Shandong Second Medical University
RECRUITING

Weifang, Shandong, 261031, China
Xuanwu Hospital Capital Medical University
RECRUITING

Beijing, Beijing Municipality, 100053, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.